Abstract

Introduction: The standard treatment method of muscle-invasive bladder cancer is radical cystectomy. This complex procedure consists of removing the urinary bladder with distal ureters and regional lymph nodes. Additionally, the prostate with seminal vesicles in men and uterus with ovaries in women should be excised. Therefore, this demanding oncological surgery is associated with a high occurrence of complications. The aim of this study was to assess the complications after radical cystectomy and identify the factors associated with severe complications and high mortality rate. Materials/Methods: We retrospectively analyzed medical data of 213 patients who underwent a radical cystectomy. Preoperative risk factors were assessed based on American Society of Anesthesiologists classification (ASA) and the Charlson Comorbidity Index (CCI). Clavien-Dindo classification was also included in our analysis. We investigated various factors associated with 30-day and 90-day mortality. Results: Complications after surgery were reported in 38% (n = 81) of patients in the studied group. Excluding perioperative high fever, the complication rate was 18%. The following complications were observed in 30-day postoperative period: wound infection (n = 6), wound dehiscence (n = 4), mechanical bowel obstruction (n = 3), hemorrhage (n = 2), cardiological (n = 8), stroke (n = 3). Observed 30-day mortality was 2.3% (n = 5), while 90-day mortality was 8.9% (n = 19). The mortality rate was associated with the stage of cancer and the type of urinary diversion. Conclusions: Radical cystectomy is a complex and traumatic urological surgery. It is associated with a significant complication rate and mortality, and it negatively affects quality of life. Therefore, all known risk factors should be thoroughly assessed preoperatively to select optimal treatment. Furthermore, the patient should be carefully informed about the risks associated with the surgery.

References

• 1. Afshar N.A., English D.R., Blakely T., ThursfieldV., Furragia H.,Giles G.G., Milne R.L.: Differences in cancer survival by area-levelsocio-economic disadvantage: A population based study using cancerregistry data. PLoS One, 2020; 15: e0228551
  Google Scholar
• 2. Altobelli E., Buscarini M., Gill H.S., Skinner E.C.: Readmissionrate and causes at 90-day after radical cystectomy in patients onearly recovery after surgery protocol. Bl. Cancer, 2017; 3: 51–56
  Google Scholar
• 3. Berger I., Martini T.,·Wehrberger C.,·Comploj E.,·PonholzerA.,·Wolfgang M.,·Breinl E., Dunzinger M.,·Hofbauer J.,·HöltlW.,·Jeschke K., Krause S.,·Kugler W. Pauer W.,·Rauchenwald M., etal.: Perioperative complications and 90-day mortality of radicalcystectomy in the elderly (75+): A retrospective, multicentre study.Urol Int., 2014; 93: 296–302
  Google Scholar
• 4. Chang C., Yin W., Wei C., Wu C., Su Y.: Adjusted age-adjustedcharlson comorbidity index score as a risk measure of perioperativemortality before cancer surgery. PLoS One, 2016; 11: e0148076
  Google Scholar
• 5. Comploj E., West J., Mian M., Kluth A., Karl A., Dechet C., ShariatS.F., Stief C.G., Trenti E., Palermo S., Lodde M., Horninger W.,Maderbacher S., Pycha A.: Comparison of complications from radicalcystectomy between old-old versus oldest-old patients. Urol.Int., 2015; 94: 25–30
  Google Scholar
• 6. Cusano A., Haddock P., Jackson M., Staff I., Wagner J., MeraneyA.: A comparison of preliminary oncologic outcome and postoperativecomplications between patients undergoing either openor robotic radical cystectomy. Int. Braz. J. Urol., 2016; 42: 663–670
  Google Scholar
• 7. Garg G., Bansal N., Singh M., Sankhwar S. N.: Role of percutaneousnephrostomy in bl9dder carcinoma with obstructive uropathy:A story revisited. Indian J. Palliat. Care, 2019; 25: 53–56
  Google Scholar
• 8. Harraz A.M., Osman Y., El-halwagy S., Laymon M., Mosbah A.,Abol-Enein H., Shaaban A.: Risk factors of hospital readmissionafter radical cystectomy and urinary diversion: analysis of a largecontemporary series. BJU Int., 2015; 115: 94–100
  Google Scholar
• 9. Hemelrijck M. V., Thorstenson A., Smith P., Adolfsson J.: Riskof in-hospital complications after radical cystectomy for urinarybladder carcinoma: population-based follow-up study of 7608 patients.BJU Int., 2013; 112: 1113–1120
  Google Scholar
• 10. Joung K.W., Kong Y.G., Yoon S.H., Kim Y.J., Hwang J.-H.,m HongB., Kim Y.-K.: Comparison of postoperative acute kidney injurybetween ileal conduit and neobladder urinary diversions afterradical cystectomy: A propensity score matching analysis. Medicine,2016; 95: e4838
  Google Scholar
• 11. Korbee M.L., Voskuilen C.S., Hendricksen K., Mayr R., Wit E.M.,van Leeuwen P.J., Horenblas S., Meinhardt W., Burger M., Bex A.,van der Poel H.G., van Rhijn B.W.G.: Prediction of early (30-day)and late (30-90-day) mortality after radical cystectomy in a comprehensivecancer centre over two decades. World J. Urol., 2019,doi: 10.1007/s00345–019–03011–2
  Google Scholar
• 12. Krajewski W., Zdrojowy R., Tupikowski K., Małkiewicz B.,Kołodziej A.: How to lower postoperative complications after radicalcystectomy – a review. Cent. Eur. J. Urol., 2016; 69: 370–376
  Google Scholar
• 13. Mani J., Vallo S., Brandt M.P., Gust K.M., Bartsch C., DaechertJ., Tsaur I., Bartsch G., Haferkamp A.: What should be the patient’spreference regarding the choice of hospital in the case of radicalcystectomy? Evaluation of early complications after open radicalcystectomy in a medium and high volume setting in one hospital.Patient Prefer Adherence, 2016; 10: 2181–2187
  Google Scholar
• 14. Marks P., Soave A., Shariat S.F., Fajkovic H., Fisch M., Rink M.:Female with bladder cancer: what and why is there a difference?Transl. Androl. Urol., 2016; 5: 668–682
  Google Scholar
• 15. Mirza A., Choudhury A.: Bladder preservation for muscle invasivebladder cancer. Bl. Cancer, 2016; 2: 151–163
  Google Scholar
• 16. Musch M., Janowski M., Steves A., Roggenbuck U., BoergersA., Davoudi Y., Loewen H., Groeben H., Kroepfl D.: Comparison ofearly postoperative morbidity after robot-assisted and open radicalcystectomy: results of a prospective observational study. BJUInt., 2014; 113: 458–467
  Google Scholar
• 17. Niegisch G., Albers P., Rabenalt R.: Perioperative complicationsand oncological safety of robot-assisted (RARC) vs. open radicalcystectomy (ORC). Urol. Oncol., 2014; 32: 966–974
  Google Scholar
• 18. Novara G., Catto J.W., Wilson T., Annerstedt M., Chan K., MurphyD.G., Motttrie A., Peabody J.O., Skinner E.C., Wiklund P.N., GuruK.A., Yuh B.:: Systematic review and cumulative analysis of perioperativeoutcomes and complications after robot-assisted radicalcystectomy. Eur. Urol., 2015; 67: 376–401
  Google Scholar
• 19. Park J.C., Citrin D.E., Agarwal P.K., Apolo A.B.: Multimodalmanagement of muscle-invasive bladder cancer. Curr. Probl. Cancer,2014; 38: 80–108
  Google Scholar
• 20. Peppone L.J., Reid M.E., Moysich K.B., Morrow G.R., Pascal J.P.,Supriya G., Mobile T.V., Darling T.V., Hyland A.: The effect of secondhandsmoke exposure on the association between active cigarettesmoking and colorectal cancer. Cancer Causes, 2010; 21: 1247–1255
  Google Scholar
• 21. Psutka S.P., Boorjian S.A., Moynagh M.R., Schmit G.D., Frank I.,Carraso A., Stewart S.B., Tarrell R., Thapa P., Tollefson M.: Mortalityafter radical cystectomy: impact of obesity versus adiposity afteradjusting for skeletal muscle wasting. J. Urol., 2015; 193: 1507–1513
  Google Scholar
• 22. Qu L.G., Lawrentschuk N.: Orthotopic neobladder reconstructionpatient selection and perspectives. Res. Rep. Urol., 2019; 11:333–341
  Google Scholar
• 23. Roghmann F., Trinh Q., Braun K., von Bodman C., Brock M.,Noldus J., Palisaar J.: Standardized assessment of complications ina contemporary series of European patients undergoing radicalcystectomy. Int. J. Urol., 2013; 21: 143–149
  Google Scholar
• 24. Russell C.M., Lebastchi A.H., Borza T., Spratt D.E., Morgan T.M.:The role of transurethral resection in trimodal therapy for muscleinvasivebladder cancer. Bl. Cancer, 2016; 2: 381–394
  Google Scholar
• 25. Soria F., Marra G., D’Andrea D., Gontero P., Shariat S.F.: Therational and benefits of the second look transurethral resectionof the bladder for T1 high grade bladder cancer. Transl. Androl.Urol., 2019; 8: 46–53
  Google Scholar
• 26. Thompson I.M., Kappa S.F., Morgan T.M., Barocas D.A., BischoffC.J., Keegan K.A., Stratton K.L., Clark P.E., Resnick M.J., Smith J.A.,Cookson M.S., Chang S.S.: Blood loss associated with radical cystectomy:A prospective, randomized study comparing impact LigaSurevs. stapling devic. Urol. Oncol., 2014; 32: e11–15
  Google Scholar
• 27. Tsaturyan A., Petrosyan V., Crape B., Sahakyan Y., AbrahamyanL.: Risk factors of postoperative complications after radical cystectomywith continent or conduit urinary diversion in Armenia.Springerplus, 2016; 5: 134
  Google Scholar
• 28. Tyson M.D., Humphreys M.R., Castle E.P.: Obese patients undergoingcystectomy: a population-based, propensity score matchedanalysis. Int. J. Urol., 2014; 21: 491–495
  Google Scholar
• 29. Wan F., Zhu Y., Gu C., Yao X., Shen Y., Dai B., Zhang S., ZhangH., Cheng J., Ye D.: Lower skeletal muscle index and early complicationsin patients undergoing radical cystectomy for bladdercancer. World J. Surg. Oncol., 2014; 12: 14
  Google Scholar
• 30. Wayan Y., Ayu P.D., Gde O.A., Wayan N., Widyadharma I.P.: Pathologicalprofile, early complications, functional and oncologicaloutcome after radical cystectomy – Ileal conduit for bladder cancerpatients in Sanglah General Hospital between January 2013 andDecember 2016. Open Access Maced. J. Med. Sci., 2018; 6: 1647–1651
  Google Scholar
• 31. Zakaria A.S., Santos F., Dragomir A., Tanguay S., Kassouf W.,Aprikian A.G.: Postoperative mortality and complications afterradical cystectomy for bladder cancer in Quebec: A populationbasedanalysis during the years 2000–2009. Can. Urol. Assoc. J.,2014; 8: 259–267
  Google Scholar
• 32. Zakaria A.S., Santos F., Tanguay S., Kassouf W., Aprikian A.G.:Radical cystectomy in patients over 80 years old in Quebec: A population–based study of outcomes. J. Surg. Oncol., 2015; 111: 917–922
  Google Scholar
• 33. Zebic N., Weinknecht S., Kroepfl D.: Radical cystectomy in patientsaged ≥ or = 75 years: an updated review of patients treatedwith curative and palliative intent. BJU Int., 2005; 95: 1211–1214
  Google Scholar

Full text